Begin typing your search above and press return to search.

Tag: Hatch-Waxman Act

What is an ANDA: Abbreviated New Drug Application Explained
Medications
9 Comments

What is an ANDA: Abbreviated New Drug Application Explained

An ANDA is the FDA pathway that lets generic drug makers prove their products are identical to brand-name drugs - without repeating costly clinical trials. It's why 90% of U.S. prescriptions are filled with generics that cost 80-85% less.

Read More
First-Mover Advantage: How First Generic Drug Manufacturers Dominate the Market
Medications
14 Comments

First-Mover Advantage: How First Generic Drug Manufacturers Dominate the Market

The first generic drug manufacturer to launch after a patent expires captures up to 80% of the market - and keeps a dominant share for years. Here’s how the Hatch-Waxman Act creates lasting advantage, why big players win, and what’s changing in 2026.

Read More